242 related articles for article (PubMed ID: 34737367)
21. Central nervous system infections caused by pathogenic free-living amoebae: An Indian perspective.
Raju R; Khurana S; Mahadevan A; John DV
Trop Biomed; 2022 Jun; 39(2):265-280. PubMed ID: 35838101
[TBL] [Abstract][Full Text] [Related]
22. Potentially pathogenic genera of free-living amoebae coexisting in a thermal spring.
Lares-Jiménez LF; Borquez-Román MA; Lares-García C; Otero-Ruiz A; Gonzalez-Galaviz JR; Ibarra-Gámez JC; Lares-Villa F
Exp Parasitol; 2018 Dec; 195():54-58. PubMed ID: 30393165
[TBL] [Abstract][Full Text] [Related]
23. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea.
Visvesvara GS; Moura H; Schuster FL
FEMS Immunol Med Microbiol; 2007 Jun; 50(1):1-26. PubMed ID: 17428307
[TBL] [Abstract][Full Text] [Related]
24. Laboratory testing of clinically approved drugs against Balamuthia mandrillaris.
Kalsoom H; Baig AM; Khan NA; Siddiqui R
World J Microbiol Biotechnol; 2014 Sep; 30(9):2337-42. PubMed ID: 24875138
[TBL] [Abstract][Full Text] [Related]
25. Innovative Methodology in the Discovery of Novel Drug Targets in the Free-Living Amoebae.
Baig AM
Curr Drug Targets; 2019; 20(1):60-69. PubMed ID: 29697029
[TBL] [Abstract][Full Text] [Related]
26. Fatal balamuthosis in a Siberian tiger and a literature review of detection options for free-living amoebic infections in animals.
Niedringhaus KD; Gordon M; Yabsley MJ; Gai J; Uzal FA; Woolard KD
J Vet Diagn Invest; 2023 May; 35(3):311-316. PubMed ID: 36908206
[TBL] [Abstract][Full Text] [Related]
27. Synthetic nanoparticle-conjugated bisindoles and hydrazinyl arylthiazole as novel antiamoebic agents against brain-eating amoebae.
Kanwal ; Mungroo MR; Anwar A; Ali F; Khan S; Abdullah MA; Siddiqui R; Khan KM; Khan NA
Exp Parasitol; 2020 Nov; 218():107979. PubMed ID: 32866583
[TBL] [Abstract][Full Text] [Related]
28. Presence of potentially pathogenic free-living amoebae strains from well water samples in Guinea-Bissau.
Baquero RA; Reyes-Batlle M; Nicola GG; Martín-Navarro CM; López-Arencibia A; Guillermo Esteban J; Valladares B; Martínez-Carretero E; Piñero JE; Lorenzo-Morales J
Pathog Glob Health; 2014 Jun; 108(4):206-11. PubMed ID: 24934796
[TBL] [Abstract][Full Text] [Related]
29. Future Priorities in Tackling Infections Due to Brain-Eating Amoebae.
Khan NA; Anwar A; Siddiqui R
ACS Chem Neurosci; 2017 Nov; 8(11):2355. PubMed ID: 28933530
[TBL] [Abstract][Full Text] [Related]
30. An Acute Case of Granulomatous Amoebic Encephalitis-Balamuthia mandrillaris Infection.
Takei K; Toyoshima M; Nakamura M; Sato M; Shimizu H; Inoue C; Shimizu Y; Yagita K
Intern Med; 2018 May; 57(9):1313-1316. PubMed ID: 29321406
[TBL] [Abstract][Full Text] [Related]
31. Clinical metagenomic identification of Balamuthia mandrillaris encephalitis and assembly of the draft genome: the continuing case for reference genome sequencing.
Greninger AL; Messacar K; Dunnebacke T; Naccache SN; Federman S; Bouquet J; Mirsky D; Nomura Y; Yagi S; Glaser C; Vollmer M; Press CA; Kleinschmidt-DeMasters BK; Dominguez SR; Chiu CY
Genome Med; 2015 Dec; 7():113. PubMed ID: 26620704
[TBL] [Abstract][Full Text] [Related]
32. Isolation of Balamuthia mandrillaris from soil samples in North-Western Iran.
Niyyati M; Karamati SA; Lorenzo Morales J; Lasjerdi Z
Parasitol Res; 2016 Feb; 115(2):541-5. PubMed ID: 26468147
[TBL] [Abstract][Full Text] [Related]
33. Discovery of Anti-Amoebic Inhibitors from Screening the MMV Pandemic Response Box on
Rice CA; Troth EV; Russell AC; Kyle DE
Pathogens; 2020 Jun; 9(6):. PubMed ID: 32560115
[TBL] [Abstract][Full Text] [Related]
34. Investigational drug available directly from CDC for the treatment of infections with free-living amebae.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(33):666. PubMed ID: 23965830
[TBL] [Abstract][Full Text] [Related]
35. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri.
Schuster FL; Guglielmo BJ; Visvesvara GS
J Eukaryot Microbiol; 2006; 53(2):121-6. PubMed ID: 16579814
[TBL] [Abstract][Full Text] [Related]
36. Detection of serum antibodies in children and adolescents against Balamuthia mandrillaris, Naegleria fowleri and Acanthamoeba T4.
Lares-Jiménez LF; Borquez-Román MA; Alfaro-Sifuentes R; Meza-Montenegro MM; Casillas-Hernández R; Lares-Villa F
Exp Parasitol; 2018 Jun; 189():28-33. PubMed ID: 29673623
[TBL] [Abstract][Full Text] [Related]
37. Diagnosing Balamuthia mandrillaris encephalitis via next-generation sequencing in a 13-year-old girl.
Wu X; Yan G; Han S; Ye Y; Cheng X; Gong H; Yu H
Emerg Microbes Infect; 2020 Dec; 9(1):1379-1387. PubMed ID: 32552393
[TBL] [Abstract][Full Text] [Related]
38. Acanthamoeba spp. and Balamuthia mandrillaris leading to fatal granulomatous amebic encephalitis.
Lee DC; Fiester SE; Madeline LA; Fulcher JW; Ward ME; Schammel CM; Hakimi RK
Forensic Sci Med Pathol; 2020 Mar; 16(1):171-176. PubMed ID: 31773473
[TBL] [Abstract][Full Text] [Related]
39. A patient with granulomatous amoebic encephalitis caused by Balamuthia mandrillaris survived with two excisions and medication.
Peng L; Zhou Q; Wu Y; Cao X; Lv Z; Su M; Yu Y; Huang W
BMC Infect Dis; 2022 Jan; 22(1):54. PubMed ID: 35032997
[TBL] [Abstract][Full Text] [Related]
40. Assessment of blood-brain barrier penetration of miltefosine used to treat a fatal case of granulomatous amebic encephalitis possibly caused by an unusual Balamuthia mandrillaris strain.
Roy SL; Atkins JT; Gennuso R; Kofos D; Sriram RR; Dorlo TP; Hayes T; Qvarnstrom Y; Kucerova Z; Guglielmo BJ; Visvesvara GS
Parasitol Res; 2015 Dec; 114(12):4431-9. PubMed ID: 26329128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]